Delivery Order SPE2DR25D1017-SPE2DR26F9DVP
- Not listed
- The Defense Logistics Agency has awarded a delivery order valued at $6,443.44 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of July 15, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,811.32 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of January 8, 2026. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The product will be delivered to the Conshohocken, Pennsylvania location, which serves as the vendor's corporate office and primary distribution hub. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on January 7, 2026, for Lidocaine 5% Patch 30s with a ceiling value of $5,336.70. This firm fixed-price delivery order is not set aside and is scheduled for ultimate completion by January 8, 2026. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch in quantities of 30 units under a firm fixed-price contract valued at $9,772.24. The order was competitively awarded with no set-aside designation and carries an ultimate completion date of November 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,508.42 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of November 12, 2025. This is a firm fixed price delivery order with no set-aside designation, issued on a competitive basis. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract under the company's larger Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $38,387.34 for Lidocaine 5% patches (30-count units) by the Defense Logistics Agency on December 31, 2025. The contract is non-competitive and structured as a firm fixed-price delivery order with an ultimate completion date of January 2, 2026. This award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $14,370.05 on August 4, 2025, for the supply of Lidocaine 5% Patch 30S, with an ultimate completion date of August 5, 2025. This non-set-aside contract utilizes firm fixed price pricing and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,319.05 by the Defense Logistics Agency on January 20, 2026, for Lidocaine 5% patches (30-count). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 21, 2026, and represents a task order executed under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a $24,856.20 delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch supplies (30-count units) on December 16, 2025, with an ultimate completion date of December 17, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $13,454.24 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch in quantities of 30 units. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of July 16, 2025. Performance will be executed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9DVPDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,678.58 for Lidocaine 5% Patch 30s on January 23, 2026, with an ultimate completion date of January 26, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle supplying military healthcare programs worldwide. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (which operates under the AmerisourceBergen brand), is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs. The company's extensive contract portfolio with the Defense Logistics Agency demonstrates its capability to supply a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, and medical devices across multiple therapeutic domains. This particular delivery order for topical lidocaine patches supports the Defense Health Agency's pain management needs for military healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 1/22/26 |